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Abstract
Background: The mammalian suprachiasmatic nucleus (SCN) is composed of heterogeneous sub-
groups of neurons that are organized into a neural system for the control of circadian physiology
and behaviour. Molecular circadian 'clocks' are not an exclusive property of SCN neurons but the
unique role of the SCN as a central integrative pacemaker is associated with specialized aspects of
neuronal organization. Current studies are aimed at identifying the functional components of this
hypothalamic integrative centre.
Results: In the present study we have identified and characterized a quite novel aspect of SCN
neurobiology, doublecortin (DCX) protein expression within a defined group of adult rat SCN
neurons. Adult neuronal DCX expression is surprising because this microtubule-associated protein
(MAP) is generally a developmentally restricted component of immature, migrating neurons. We
have also demonstrated for the first time that the SCN as a whole exhibits low expression of the
neuronal differentiation marker NeuN. However, DCX is co-localized with NeuN in the ventral
SCN, and also with neuropeptides; DCX is extensively co-localized with GRP and partially co-
localized with VIP.
Conclusion: The highly selective expression of DCX in the adult SCN compared with other
hypothalamic and thalamic nuclei shows that this MAP is somewhat uniquely required in certain
SCN neurons, perhaps contributing to a specific functional property of the brain's circadian clock
nucleus. DCX may maintain a capacity for dynamic cellular plasticity that subserves daily alterations
in SCN neuronal signalling.
Background
Doublecortin is a brain-specific gene, first identified in
1998, that is mutated in two human neurodevelopmental
disorders: X-linked lissencephaly and double cortex syn-
drome [1]. 'Double cortex syndrome' provides the com-
monly used shorter name for doublecortin, 'DCX'. DCX
encodes a 40 kDa (UniProt predicted size) cytoplasmic
protein (sometimes called doublin) that interacts with
tubulin and is thereby a microtubule-associated protein
(MAP) [2]. DCX regulates the assembly and stabilization
of microtubule 'tracks', actions that appear to enhance
molecular motor function [3,4]. DCX protein is now
known to be part of a super-family of proteins that are
related through a doublecortin homology domain [5].
DCX is present in immature (differentiating and migrat-
ing) neurons and is considered a marker for this stage of
neurogenesis [see 6]. DCX regulates the migration of mul-
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actions at the distal ends of neurites that promote neurite
extension [3,7]. In the juvenile and adult brain, the
expression of DCX is massively reduced compared with
neonatal animals and has been shown to be restricted to
a limited number of specialized neuronal cell groups, for
example in the rostral migratory stream [8]. In the present
study we have identified and characterized a group of
adult DCX+ neurons that has not been recognized previ-
ously. These neurons are within a specific sub-division of
the hypothalamic suprachiasmatic nucleus (SCN) which
is the site of the 'master' circadian clock in the brain
[9,10].
Results
DCX is expressed in the ventral suprachiasmatic nucleus
Immunohistochemical analysis of rat brain sections
(postnatal day [P] 25) using a rabbit anti-DCX antibody
confirmed that expression of DCX is highly restricted at
this age. One of the scarce groups of DCX+ neurons main-
tained at P25 [8] is located in the sub-ventricular zone
(SVZ, Fig. 1B). In this study we have now made the novel
observation that another cell group expressing abundant
DCX immunoreactivity at this time is the suprachiasmatic
nucleus (SCN) of the hypothalamus (Fig. 1B). The novelty
of this finding is emphasized in Fig. 1B. by the scarcity of
DCX+ cell groups at this age; note the absence of detected
immunoreactivity across the entire intervening thalamic
and hypothalamic regions between the SVZ and the SCN.
Closer inspection of the SCN showed that DCX immuno-
reactivity is highly localized to the ventral SCN with some
cell bodies embedded in the dorsal optic chiasm (Figs. 1C
&1D). High magnification microscopy (Fig. 1E) revealed
that DCX immunoreactivity is located both in the cyto-
plasm of SCN cell bodies and in processes that course
through the ventral SCN.
DCX expression is a constitutive property of the adult SCN
The identity of DCX immunoreactivity in this novel site
was confirmed in two ways. First, it was shown that neu-
tralization of the antibody with the peptide immunogen
blocked detection of SCN reactivity (Fig. 2A–C). Second,
using a different, previously characterized goat anti-DCX
antibody [11,12], the same pattern of SCN DCX was
observed (see Figs. 4G &4J). Furthermore, in order to con-
firm that the SCN DCX immunoreactivity was not a phe-
nomenon restricted to one species/strain we
demonstrated that DCX was similarly localized to the ven-
tral SCN of mice (CD1 strain; not shown).
P25 rats were used in these initial studies because SCN
innervations achieve adult-like levels at this juvenile stage
of development [13]. In order to confirm that DCX
expression is maintained in the adult SCN, we conducted
further studies in adult rats, demonstrating that DCX
expression is maintained in the adult rat SCN, at a slightly
lower overall level compared with P25 brain (Fig. 2B vs.
2D).
Many proteins are expressed in a rhythmic (circadian)
manner within SCN clock neurons [10]. We therefore
examined DCX levels in adult rats during the light:dark
cycle (Fig. 2E). Measurement of SCN DCX immunoreac-
tivity at four time points, across three rostro-caudal loca-
tions, revealed no significant changes in DCX levels (Fig.
2E; ANOVA: 0.48 mm from bregma: F = 0.491, p = 0.870;
0.72 mm: F = 1.028, p = 0.527; 0.96 mm: F = 0.704, p =
0.736). Additionally, we did not observe any time-related
changes in the location of DCX within the SCN. DCX pro-
tein expression is therefore a constitutive property of the
adult SCN. During this analysis we also observed that
DCX is highly restricted to the SCN with respect to adja-
cent rostral and caudal hypothalamic cell groups; it is not
observed immediately rostrally in the ventromedial pre-
optic nucleus, nor immediately caudally in the retrochias-
matic area (not shown).
Expression of the neuronal differentiation marker NeuN is 
low in the SCN
The presence of DCX in the identified population of SCN
cells suggested the possibility that these may be undiffer-
entiated neuroblasts that, accordingly, do not express cer-
tain neuron-specific proteins. We therefore examined
expression of NeuN, a marker of differentiation within
most populations of CNS neurons [14] that is not
expressed in the SVZ DCX+ cells (present study, not
shown). Interestingly, we made the novel observation that
the adult rat SCN expresses a low level of NeuN compared
with the surrounding hypothalamic neurons (Fig. 3). At
the same time, however, those cells in the SCN that did
express detectable levels of NeuN were clustered in the
ventral SCN, the region where DCX is also expressed (Fig.
3B &3C).
DCX is expressed in NeuN+ neurons of the SCN
Dual immunohistochemical detection of DCX and NeuN
(Figs. 3D–F) revealed that NeuN was indeed present in the
majority of DCX-positive cells although rare NeuN-nega-
tive/DCX+ cells were observed. The majority of DCX+
cells in the adult SCN are therefore confirmed as neuro-
nal. Many of the DCX+ SCN cells were observed to express
a low relative level of NeuN compared to many surround-
ing DCX-negative cells (Fig. 2E).
DCX is co-expressed with GRP and VIP in the SCN
The presence of DCX+ neuronal cell bodies in the ventral
SCN suggested that these cells have identity to (one or
more of) the neuropeptide-expressing cell groups that are
distributed in the SCN. With reference to the mapping of
these groups [9] we reasoned that the most likely co-local-Page 2 of 9
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vasoactive intestinal peptide (VIP) and gastrin-releasing
peptide (GRP). In order to identify the cell-proup(s) in the
SCN that express DCX we therefore compared DCX with
these neuropeptides on adjacent brain sections (Figs.
4A–F). Notably, for each of the three SCN neuropeptides
examined, immunoreactivity was considerably more dis-
persed across the ventral hypothalamus compared with
DCX. This was particularly notable for SSt where strongly
immunoreactive soma in the periventricular area did not
express detectable DCX. Also, within the SCN, the distri-
bution of DCX was quite unlike that of SSt which is heav-
ily concentrated in the medioventral SCN. In contrast,
although GRP+ and VIP+ fibres were again abundantly
dispersed outside of the SCN, the intra-SCN distribution
of these two neuropeptides closely resembled that of
Groups of DCX-positive cells in the rat brain are limited to a few sites including the ventral SCNFigure 1
Groups of DCX-positive cells in the rat brain are limited to a few sites including the ventral SCN. A. Brain atlas 
image showing the SVZ and the SCN. B. Photomicrograph of DCX immunoreactivity within the region boxed in A. Note that 
groups of DCX+ cells are located only in the SVZ and SCN. Scale bar below image = 300 μm. C & D. Photomicrographs of 
DAPI-labelled and DCX-immunoreactive cells showing the location of DCX-immunoreactive cells within the ventral region of 
the SCN. Note the presence of some DCX-immmunoreactive cell bodies that are embedded in the optic chiasm. Scale bar = 
50 μm. E. 20 μm. Abbreviations: 3V, third ventricle; OC, optic chiasm; SVZ, sub-ventricular zone.Page 3 of 9
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co-localization studies were conducted with respect to
GRP and VIP.
Dual immunohistochemical detection of DCX and GRP
showed that these two proteins are widely co-expressed in
the ventral SCN (Figs. 4G–I). Some DCX+/GRP-negative
neurons were consistently observed (Fig. 4G) indicating
that DCX is not confined to the GRP group (also see
below). In contrast, it was not possible to discern DCX-
negative/GRP+ neurons; low relative levels of GRP were
present in some DCX+ neurons (Fig. 4H) but nevertheless
this immunoreactivity was above background. In this
respect it should be noted that GRP was not detectable in
DCX+ neurons of the SVZ, and conversely, DCX was not
detectable in GRP+ neurons of the lateral septal nuclear
area (not shown).
DCX is also co-localized with VIP (Figs. 4J–4L), although
to a much lesser extent than for GRP. Again, DCX+/VIP-
Verification of SCN DCX immunoreactivity and comparative expression in the juvenile and adult ratFigure 2
Verification of SCN DCX immunoreactivity and comparative expression in the juvenile and adult rat. A-D. 
Photomicrographs of DCX-immunoreactivity and DAPI staining in the ventral hypothalamus of the rat brain. Brain sections 
were from either P25 (A-C) or adult (6 month, D) rats. Brain sections were incubated with either control (A, B, D) or neutral-
ized (C) anti-DCX antibody. A-C. Immuno-neutralization blocks detection of DCX in the SCN. Note that the camera expo-
sure time of image C was longer relative to that of image B in order to reveal some background fluorescence. D. Note that 
DCX immunoreactivity in the adult is similarly distributed in the SCN, but at a lower relative level compared with the PN25 
sample. Scale bar = 100 μm. Abbreviations: 3V, third ventricle; OC, optic chiasm. E. Absence of rhythmic DCX expression in 
the adult SCN. Histogram showing levels of DCX immunoreactivity at three rostro-caudal brain levels (-0.48, -0.72, -0.96 mm 
from bregma) measured at four time points. Levels (Leica Qwin Mean Grey level) are the mean ± S.E.M of six measurements (2 
samples of SCN from each of 3 rats). Statistical analysis (ANOVA; see text) revealed no significant changes across time.Page 4 of 9
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VIP, many VIP+ cells were DCX-negative (Fig. 4K). An
abundance of VIP+ neurons embedded in the optic chi-
asm (Fig. 4F) compared with the relative absence of simi-
larly localized DCX+ neurons in Fig. 4E. is illustrative of
the relative separation of these two cell groups compared
with the DCX and GRP groups.
Discussion
Suprachiasmatic nucleus – a novel site of DCX expression 
in the adult brain
DCX is a required component of migrating neurons that is
accordingly highly expressed only during foetal and neo-
natal stages of brain development [2]. Western blot anal-
ysis of whole rodent brain shows that DCX protein levels
are maximal at the time of birth (P0), markedly reduced
by P10 and barely detectable in adult brain [see 15]. DCX
expression is maintained in some adult neurons but these
are scarce, specific exceptions that include a migratory
stream of cells associated with the olfactory system [14].
Our finding that DCX is also expressed in neurons of the
adult SCN is therefore a significant addition to our under-
standing of the adult roles of DCX. Furthermore, our find-
ings add a potentially important new avenue of research
into the molecular and functional organization of the
SCN.
The mammalian SCN is a discrete and yet complex neuro-
nal cell group that has been extensively characterized in
recent years. This hypothalamic nucleus is the subject of
intense study because it forms the brain's 'master' circa-
dian clock, coordinating daily rhythms of central and
peripheral physiology, rhythms that impact upon health
and disease [10,16]. Molecular circadian clocks are not an
exclusive property of SCN cells [16] but the intrinsic
organization and extrinsic connections of the SCN pro-
vide it with a unique and central position in circadian
control. The SCN contains many different neurotransmit-
ters and neuropeptides [9,17], neurochemical compo-
nents that subserve both inputs to the SCN [9,18] and also
outputs that effect control over autonomic physiology
[19]. Our finding that the SCN is, with respect to other
The SCN is a region of low NeuN expression in the adult brain but SCN DCX is localized in NeuN+ neuronsFigure 3
The SCN is a region of low NeuN expression in the adult brain but SCN DCX is localized in NeuN+ neurons. 
A-C: Photomicrographs of one field within the ventral hypothalamus of the adult rat brain showing NeuN in neurons and the 
absence of NeuN within OC glia. Note the low expression of NeuN in the SCN, particularly in the dorsal region. The bound-
aries of the SCN are marked with dashed lines. Scale bar = 100 μm. D-F: Photomicrographs of neurons within one field of the 
ventral SCN showing the localization of DCX within NeuN-positive neurons. Note the low relative level of NeuN in the DCX-
positive, and some other cells (single arrowheads) compared with the higher level in the majority of DCX-negative cells (exam-
ples indicated with double arrowheads in E). Scale bar = 20 μm. Abbreviations: 3V, third ventricle; OC, optic chiasm.Page 5 of 9
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adult DCX expression suggests that DCX is somewhat
uniquely required in these SCN cells, and may therefore
confer a specific property required for circadian function.
Suprachiasmatic nucleus – a brain region of low NeuN 
expression
A second novel and interesting finding of the present
study is that the SCN is a region of low NeuN expression.
This finding would appear to be in accord with high DCX
expression because down-regulation of DCX in differenti-
ating neurons coincides with up-regulation of the mature
DCX is expressed in GRP neurons and a sub-population of VIP neuronsFigure 4
DCX is expressed in GRP neurons and a sub-population of VIP neurons. Photomicrographs of adult rat hypothalamus 
showing the comparative distribution of DCX and neuropeptide immunoreactivity. A&B. Adjacent sections showing DCX and 
somatostatin (SSt). C&D. Adjacent sections showing DCX and GRP. E&F. Adjacent sections showing DCX and VIP. Scale bar 
= 100 μm. G-I. Dual colour immunohistochemistry showing extensive co-localization of DCX and GRP. Co-localizing neurons 
are indicated by vertical arrows. An individual neuron with low but detectable GRP is indicated with a horizontal arrow. In G, 
a DCX+/GRP-negative neuron is indicated with a vertical arrow. J-L. Dual colour immunohistochemistry showing partial co-
localization of DCX and VIP. Co-localizing neurons are indicated by vertical arrows in L. In J, a DCX+/VIP-negative neuron is 
indicated, and in K, a VIP+/DCX-negative neuron is indicated. Scale bar = 20 μmPage 6 of 9
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found an apparently paradoxical inverse correlation in
that NeuN is undetectable only in dorsal SCN neurons,
whereas DCX is restricted to ventral SCN neurons, and is
generally co-localized with NeuN. The functional signifi-
cance of reduced NeuN expression in the SCN is unclear
because although a limited number of other neurons
including cerebellar Purkinje cells, and retinal phorecep-
tors do not express NeuN [14], the physiological role of
this protein remains undefined. However, our finding
defines an additional unusual property of SCN cells, in
this case dorsal SCN neurons, that may relate to circadian
function.
DCX is expressed in GRP neurons and a sub-population of 
VIP neurons
DCX is expressed in the ventrolateral 'core' region of the
SCN within particular neuropeptide-expressing cells. Our
analysis has shown that DCX is located in both GRP+ and
VIP+ neurons; all GRP+ neurons appear to be DCX+
whereas only a minority of VIP+ neurons co-express DCX.
Previous studies have demonstrated a small population of
VIP+/GRP+ neurons in the SCN [20]; additional reagents
are required to determine whether DCX is present in such
cells. The detection of a minority of DCX+/GRP-negative
neurons indicates that the DCX+ population in the rat
SCN is not identical to the GRP+ population. Neverthe-
less, the extensive co-localization of DCX and GRP is
clearly indicative of a particular requirement for DCX in
this population of neurons. Unlike SCN VIP which has
been functionally characterized in mutant animal models
[21], the role of the GRP in the SCN is less well defined.
However, GRP, which is expressed in 14% of SCN neu-
rons [9], appears to play a broadly similar role in linking
SCN input to changes in clock neuronal activity [22-24].
An apparent redundancy between VIP and GRP function
in the SCN may be reconciled by a specific property that is
conferred on the GRP neurons by DCX.
DCX function and plasticity-related molecules in the SCN
The functional role of DCX in the SCN is unknown. A spe-
cific action in circadian clock function can be inferred
from the highly localized expression within this nucleus.
Our observation that DCX levels do not change across the
daily light/dark cycle cannot be taken as evidence that
there is no rhythmic change in DCX activity because
potential changes in DCX phosphorylation state mediated
by JNK and/or cdk5 [7,25] may affect DCX function [7].
The possible involvement of JNK in modulating the activ-
ity of SCN DCX is intriguing because there is evidence that
JNK regulates circadian rhythms [26].
In a previous study of adult neuronal DCX expression [8]
it was suggested that the maintenance of adult expression
is required for microtubule-related 'plasticity' in synaptic
organization. In this respect, another plasticity-related
molecule, the polysialated form of the neural cell adhe-
sion molecule (PSA-NCAM), which is co-expressed with
DCX during neuronal development [6], is also found in
the adult SCN [27]. Therefore, DCX, together with other
plasticity-related molecules, may mediate rhythmic
changes in SCN synaptic organization that underlie day/
night changes in electrical signalling [28]. Finally, our cur-
rent findings may relate to the capability that exists for
functional transplantation of the SCN [29]. The cellular
requirements for this property have been considered
before [30]; now it may be of value to investigate the
DCX+ SCN sub-population that we have identified here.
Conclusion
In this study we have identified two novel aspects of
suprachiasmatic nucleus (SCN) organization: (i) adult
expression of the immature neuronal marker protein,
DCX, in a ventral SCN population of GRP/VIP neurons,
and (ii) low SCN expression of the mature neuronal
marker protein, NeuN. These findings are important for
two reasons. Firstly, they are relevant to our understand-
ing of the molecular mechanisms that control neuronal
differentiation, identifying, for example, a model system
that can be used to address the pathways that permit adult
expression of DCX. Secondly, the restriction of these
immature neuronal characteristics to particular regions/
neurons of the SCN suggests a specific relevancy to the
functional competence of these SCN components.
Methods
Experimental animals
Animal studies were conducted in accordance with both
UK Home Office regulations, and local ethical review.
Animals were maintained in a 14:10 light:dark cycle
(lights on: 05.00 h). Male Sprague-Dawley rats were used
(juvenile [P25], or adult, 3–6 month) apart from one
experiment where adult CD1 mice (4 month) were used
to confirm DCX expression in a second species. Each
immunohistochemical analysis was conducted on a min-
imum of four brain sections sampled from each of two
animals. Brains were sampled at 12.00 h apart from one
experiment where an analysis of rhythmic expression was
conducted. Rats were anaesthetized with sodium pento-
barbitone (150 mg/kg, i.p.) and perfused via the ascend-
ing aorta with phosphate buffered saline followed by 4%
paraformaldehyde in 0.1 M phosphate buffer (PFA). Tis-
sues were then post-fixed in PFA for 90 min at 4°C, and
cryoprotected in 20% sucrose in 0.1 M phosphate buffer
at 4°C. Tissues were then frozen on dry-ice, and stored at
-70°C prior to sectioning.
Immunohistochemical analysis
Brains sections (10 μm) were cut using a Bright OTF cryo-
stat (Bright Instrument Company Limited, Huntingdon,Page 7 of 9
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International, Poole, Dorset, UK). Sections were treated
with 0.01 M citrate buffer, pH 6.0, at 60°C for 2 h. Pro-
teins/peptides were detected either using either a standard
immunohistochemical procedure [31] or alternatively
using the tyramide signal amplification (TSA) procedure
according to the manufacturer's protocol (PerkinElmer,
Waltham, MA, USA). Dual detection of proteins was
accomplished by using the TSA procedure, followed by
the standard procedure for a second protein. Prior to the
TSA procedure, sections were additionally treated with
hydrogen peroxide, 1.5% in methanol, for 20 mins.
The following primary antisera were used: rabbit anti-
doublecortin (rabbit), ab18723, abcam, Cambridge, UK;
anti-doublecortin (goat), sc-8066, Santa Cruz Biotechnol-
ogy, Santa Cruz, CA, USA; anti-GRP, ab22623, abcam;
anti-NeuN, MAB377, Chemicon International, Temecula,
CA, USA; anti-somatostatin, T4103, Peninsula; anti-VIP,
T-4246, Peninsula. These were used in combination with
the appropriate biotin/fluorophore-conjugated, second-
ary antisera: biotin-conjugated donkey anti-rabbit IgG,
abcam; Alexa Fluor 488-conjugated donkey anti-goat IgG,
Molecular Probes Inc, Eugene, OR, USA; Alexa Fluor 568-
conjugated goat anti-mouse IgG, Molecular Probes; Cy3-
conjugated sheep anti-rabbit IgG, Sigma. In control exper-
iments, aliquots of the rabbit doublecortin antibody and
the GRP antibody were incubated with an excess of the
peptide immunogens (doublecortin: ab19804, abcam;
GRP: G8022, Sigma, St. Louis, MO, USA; overnight, 4°C)
prior to the TSA procedure. For both antibodies, this
absorption/neutralization procedure blocked detection of
the respective protein/peptide (doublecortin: see Fig. 2.
GRP; not shown). Following final washing, sections were
mounted under coverslips using Vectashield with DAPI
(Vector Laboratories, Burlingame, CA, USA).
Brain sections were viewed using either an epifluorescence
(Leica DM-LB, Leica Microsystems Imaging Solutions Ltd,
Cambridge, UK) or laser confocal microscope (Leica TCS-
SP2-AOBS). Images were captured using either a Leica
DFC-300FX digital camera and Leica QWin software (V3)
or Leica Confocal Software, and montaged in Photoshop
(CS2, Adobe Systems Inc., San Jose, CA, USA). QWin soft-
ware was also used to obtain measurements of neuronal
fluorescence intensity: greyscale images (X200) were cap-
tured and Mean Grey levels were determined in a sample
rectangle (30–40 k pixels). A similar sample was meas-
ured in the adjacent optic chiasm region to serve as a (sub-
tracted) control for background. Two samples of SCN
fluorescence, at three rostro-caudal levels were obtained
from 12 rat brains (3 rats at each of 4 time points: see
Results). Rat brain map images were downloaded from
the Rat Brain Atlas [32] and modified in Photoshop.
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